News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,622 Results
Type
Article (39639)
Company Profile (247)
Press Release (657736)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204138)
Career Advice (2007)
Deals (35414)
Drug Delivery (95)
Drug Development (81033)
Employer Resources (172)
FDA (16171)
Job Trends (14851)
News (345132)
Policy (32529)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2553)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49414)
ALS (86)
Alzheimer's disease (1371)
Antibody-drug conjugate (ADC) (115)
Approvals (16174)
Artificial intelligence (242)
Autoimmune disease (20)
Automation (15)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (104)
Biotechnology (175)
Bladder cancer (63)
Brain cancer (26)
Breast cancer (268)
Cancer (2122)
Cardiovascular disease (170)
Career advice (1674)
Career pathing (29)
CAR-T (145)
Cell therapy (406)
Cervical cancer (19)
Clinical research (65871)
Collaboration (803)
Compensation (517)
Complete response letters (19)
COVID-19 (2583)
CRISPR (37)
C-suite (227)
Cystic fibrosis (100)
Data (2073)
Decentralized trials (2)
Denatured (17)
Depression (41)
Diabetes (260)
Diagnostics (6352)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86371)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (111968)
Executive appointments (703)
FDA (17373)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (725)
Gene editing (100)
Generative AI (19)
Gene therapy (285)
GLP-1 (702)
Government (4408)
Grass and pollen (4)
Guidances (51)
Healthcare (18812)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (110)
Indications (27)
Infectious disease (2723)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (311)
IPO (16497)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (36)
Layoffs (461)
Leadership (16)
Legal (7908)
Liver cancer (72)
Lung cancer (306)
Lymphoma (143)
Machine learning (5)
Management (58)
Manufacturing (290)
MASH (63)
Medical device (13351)
Medtech (13356)
Mergers & acquisitions (19440)
Metabolic disorders (664)
Multiple sclerosis (76)
NASH (16)
Neurodegenerative disease (83)
Neuropsychiatric disorders (26)
Neuroscience (1882)
NextGen: Class of 2025 (6513)
Non-profit (4476)
Northern California (2562)
Now hiring (38)
Obesity (358)
Opinion (204)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (225)
Patient recruitment (103)
Peanut (46)
People (57236)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20510)
Phase II (29002)
Phase III (21624)
Pipeline (1122)
Policy (132)
Postmarket research (2563)
Preclinical (8678)
Press Release (64)
Prostate cancer (99)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (372)
Real estate (5906)
Recruiting (65)
Regulatory (22219)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (126)
Series B (81)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2195)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (28)
The Weekly (28)
United States (22216)
Vaccines (670)
Venture capitalists (40)
Weight loss (231)
Women's health (34)
Worklife (15)
Date
Today (127)
Last 7 days (455)
Last 30 days (2410)
Last 365 days (32833)
2025 (9517)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37780)
Australia (6179)
California (5842)
Canada (1955)
China (495)
Colorado (258)
Connecticut (264)
Delaware (136)
Europe (81060)
Florida (869)
Georgia (202)
Idaho (57)
Illinois (516)
India (25)
Indiana (303)
Iowa (10)
Japan (153)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (865)
Massachusetts (4366)
Michigan (216)
Minnesota (382)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1668)
New Mexico (28)
New York (1674)
North Carolina (943)
North Dakota (7)
Northern California (2562)
Ohio (196)
Oklahoma (14)
Oregon (33)
Pennsylvania (1314)
Puerto Rico (11)
Rhode Island (32)
South America (1096)
South Carolina (21)
South Dakota (1)
Southern California (2195)
Tennessee (100)
Texas (871)
Utah (173)
Virginia (139)
Washington D.C. (60)
Washington State (540)
West Virginia (3)
Wisconsin (51)
697,622 Results for "tasso inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SNBL and Tasso, Inc. to Establish Joint Venture in Japan
March 28, 2025
·
2 min read
BioForest
Tasso Announces Launch of Tasso Care® for Prescreening
Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, announced the launch of Tasso Care® for Prescreening, an end-to-end services solution to maximize the success of a prescreening program.
February 8, 2024
·
2 min read
Press Releases
Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research Biomarker Testing
February 3, 2025
·
3 min read
Business
The Leukemia & Lymphoma Society and Tasso Announce Partnership to Advance Blood Cancer Research
The Leukemia & Lymphoma Society®, a global leader in the fight against blood cancer, and Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, announced a collaboration to accelerate blood cancer research.
May 30, 2024
·
3 min read
BioForest
Tasso Receives CE Mark Certification for Tasso+™, Latest Generation Whole Blood Collection Lancet Device
Tasso, Inc. today announced it received CE Mark certification for its Tasso+™ device, a convenient, virtually pain-free blood lancet that collects whole liquid blood samples.
September 19, 2023
·
2 min read
BioForest
Tasso Recommended for Certification from Medical Device Single Audit Program (MDSAP)
Tasso, Inc. today announced that it has been recommended for certification from the Medical Device Single Audit Program (MDSAP), under which a single regulatory audit of a medical device manufacturer may satisfy the requirements of multiple regulatory jurisdictions participating in the program.
May 18, 2023
·
2 min read
Business
Tasso and UBC Partner to Advance Decentralized Sample Collection and Analysis Solutions for Post-Approval Research
Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, and United BioSource LLC (UBC) today announced a partnership to provide more efficient, streamlined, and convenient sample collection and analysis options for post-approval research to improve study design and enable a better patient experience.
June 27, 2023
·
3 min read
BioForest
Tasso High-Volume Liquid Blood Collection Device Earns CE Mark Certification
Tasso, Inc. today announced that the TassoOne™ Plus, a new high-volume liquid blood collection device, has received CE Mark certification and successfully fulfilled all of the performance, safety, and relevant product requirements under the new European Union Medical Device Regulation.
February 14, 2023
·
2 min read
FDA
Tasso+™ Device Earns FDA 510(k) Class II Medical Device Clearance
Tasso, Inc., the leading provider of convenient, clinical-grade blood collection solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Tasso+™ lancet as a Class II medical device.
September 14, 2022
·
2 min read
Business
Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors
Evelo Biosciences, Inc. announced that John Maraganore, Ph.D., founder and longtime former CEO of Alnylam Pharmaceuticals, and Tassos Gianakakos, the longtime former CEO of MyoKardia, have joined Evelo as strategic advisors.
April 21, 2022
·
5 min read
1 of 69,763
Next
